Mumbai-based AI diagnostics startup Qure.AI has raised $65 million in a Series D funding round led by Lightspeed Venture Partners and 360 ONE Asset Management. New investors such as Merck Global Health Innovation Fund and Kae Capital joined existing backers Novo Holdings, Health Quad, and TeamFund in the round.
The funding will support Qure.AI’s global expansion, particularly in the US, and the development of its generative AI foundation models. The company also plans to explore strategic acquisitions. Founded in 2016, Qure.AI uses AI to detect and manage critical diseases and currently operates in over 3,000 imaging sites across 90 countries, with regulatory approval from the US and EU.
